Swan Calamine Lotion Nationwide Recall for Temperature Storage Deviations
Family Dollar Stores is recalling Swan Calamine Lotion 6 FL OZ due to CGMP deviations involving improper storage temperature. No illnesses or injuries have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II FDA recall for CGMP storage deviations with no reported illnesses or injuries. The hazard is theoretical product degradation from improper temperature storage, making this a precautionary recall typical of storage quality issues.
Plain-English summary
Swan Calamine Lotion 6 FL OZ is being recalled due to Good Manufacturing Practice (CGMP) deviations. Specifically, the product was stored outside appropriate temperature conditions.
The recalled product was distributed nationwide to specific Family Dollar Stores locations between April 30, 2022 and June 10, 2022. The affected product has SKU 901469.
No illnesses or injuries related to this recall have been reported. The recalling firm, Family Dollar Stores, LLC, initiated this recall as a precautionary measure.
Consumers who purchased this product during the affected period should stop using it and contact their local Family Dollar Store for return or replacement information.
The recalled product
- Product
- SWAN CALAMINE LOTION 6 FL OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 901469
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27